Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

AmerisourceBergen Promotes Michael D. Dicandilo To Executive Vice President And Chief Financial Officer

By Pharmaceutical Processing | May 17, 2005

AmerisourceBergen Corporation recently announced that its Board of Directors has elected Michael D. DiCandilo, 44, Executive Vice President and Chief Financial Officer of the Company, effective immediately. DiCandilo, who was previously senior vice president and chief financial officer of the Company, will continue to report to R. David Yost, AmerisourceBergen’s Chief Executive Officer.

“Mike’s election as executive vice president is recognition of his outstanding contributions to AmerisourceBergen, and the expectation that he will continue to play a significant leadership role in driving the Company’s performance,” said Yost.

Prior to being named senior vice president and chief financial officer of AmerisourceBergen in 2002, DiCandilo was appointed Vice President and Corporate Controller in 2001, shortly after the merger of AmeriSource Health and Bergen Brunswig. He joined the former AmeriSource 15 years ago as Regional Vice President of Finance for the company’s Northeast Region. Five years later, DiCandilo was appointed AmeriSource’s Vice President and Controller. Prior to joining AmeriSource, he served eight years with Ernst & Young in a variety of accounting management positions.

DiCandilo is a Certified Public Accountant and holds a Bachelor of Science degree in accounting from the Wharton School of the University of Pennsylvania, where he graduated summa cum laude.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE